Who Makes Breyanzi? A Look at the Manufacturer Behind This CAR T-Cell Therapy
•
4 min read
Bristol Myers Squibb is the global biopharmaceutical company that currently makes Breyanzi, a highly specialized and personalized CAR T-cell therapy. The medication's journey to market is the result of a series of corporate acquisitions, with its origins tracing back to the biotechnology company Juno Therapeutics.
